Factor X Inhibitor: A Fulminant Presentation and Fatal Course of a Rare Syndrome in a 59-Year-Old Male | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Factor X Inhibitor: A Fulminant Presentation and Fatal Course of a Rare Syndrome in a 59-Year-Old Male

Acta Haematol (2013) 129 (1): 40–44.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis

P. Rossignon
F. Grandjean
A. Claessens
N. Weynants
Håkon Reikvam

Case Reports in Hematology (2023) 2023: 1.

Management of Acquired Factor X Deficiency Caused by In Vitro Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid Therapy

Akio Onishi
Yuji Shimura
Takahisa Nakamura
Masayoshi Souri
Tsukasa Osaki
Shinsuke Mizutani
Taku Tsukamoto
Tsutomu Kobayashi
Akitada Ichinose
Junya Kuroda

Internal Medicine (2023) 62 (16): 2401.

Autoimmune Coagulation Factor X Deficiency as a Rare Acquired Hemorrhagic Disorder: A Literature Review

Akitada Ichinose
Tsukasa Osaki
Masayoshi Souri

Thrombosis and Haemostasis (2022) 122 (03): 320.

Successful treatment of a noninhibitory antibody‐mediated acquired factor X deficiency in a patient with marginal‐zone lymphoma

Annemarie Meenhuis
Rianne van Vliet
Francisca Hudig
Paula F. Ypma
Martin R. Schipperus
Martine J. Hollestelle

Clinical Case Reports (2015) 3 (7): 587.

An acquired, calcium-dependent, factor X inhibitor

George J. Broze

Blood Cells, Molecules, and Diseases (2014) 52 (2-3): 116.